These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30410356)

  • 1. Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer.
    Shi H; Huang H; Pu J; Shi D; Ning Y; Dong Y; Han Y; Zarogoulidis P; Bai C
    Onco Targets Ther; 2018; 11():6995-7003. PubMed ID: 30410356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
    Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
    Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
    Liu MM; Chen ZH; Zhao LY; Zhao JY; Rong DL; Ma XK; Ruan DY; Lin JX; Qi JJ; Hu PS; Wen JY; Chen J; Lin Q; Wu XY; Wei L; Dong M
    Oncol Res Treat; 2021; 44(9):450-468. PubMed ID: 34380137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.
    Lu J; Wang Y; Yan M; Feng P; Yuan L; Cai Y; Xia X; Liu M; Luo J; Li L
    Oncotarget; 2016 Jul; 7(27):41758-41766. PubMed ID: 27248178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between Pretreatment Serum Apolipoprotein Level and Prognosis of Small Cell Lung Cancer Patients].
    Dong Y; Wang H; Shan D; Zhang L; Yu Z
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):845-851. PubMed ID: 33070513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the serum apolipoprotein B to apolipoprotein A-I ratio in metastatic colorectal cancer patients.
    Yang DD; Chen ZH; Wang DS; Yu HE; Lu JH; Xu RH; Zeng ZL
    J Cancer; 2020; 11(5):1063-1074. PubMed ID: 31956353
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer.
    Xu CH; Yang Y; Wang YC; Yan J; Qian LH
    Oncotarget; 2017 Apr; 8(14):22483-22489. PubMed ID: 28160556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer.
    Ye J; Luo QY; Wang XP; Liu ZY; Chen MX; Huang H; Zhang L
    Cancer Manag Res; 2019; 11():9265-9276. PubMed ID: 31802946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
    Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
    Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
    Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
    BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer].
    Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
    Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
    Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer.
    Cheng T; Dai X; Zhou DL; Lv Y; Miao LY
    Med Oncol; 2015 Jan; 32(1):407. PubMed ID: 25465061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
    Zhou GH; Yang WH; Sun B
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5696-5701. PubMed ID: 29272005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.